Skip to main content

Table 2 Tumor SUVs at early (12 min) and late (60 min) time points after [ 11 C]erlotinib injection

From: Identifying erlotinib-sensitive non-small cell lung carcinoma tumors in mice using [11C]erlotinib PET

Tumor type Early SUV Late SUV
QG56 0.338 ± 0.039* (6) 0.195 ± 0.010**, *** (6)
HCC827 0.598 ± 0.013 (4) 0.709 ± 0.069 (7)
HCC827 + block 0.424 ± 0.046** (5) 0.298 ± 0.029** (5)
NCI-H3255 0.427 ± 0.014** (6) 0.328 ± 0.089** (6)
NCI-H1975 0.326 ± 0.032* (8) 0.209 ± 0.028**, *** (8)
  1. Results are presented as mean ± SD, and the number of scanned tumors is indicated in brackets. *p < 0.001 with respect to HCC827 and NCI-H3255 tumors. **p < 0.001 with respect to HCC827 tumors. ***p < 0.01 with respect to NCI-H3255 tumors.